CVRX
CVRx, Inc.
$6.83
-6.69%
2026-05-08
About CVRx, Inc.
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Key Fundamentals
Forward P/E
-3.67
EPS (TTM)
$-2.04
ROE
-96.6%
Revenue Growth (YoY)
4.4%
Profit Margin
-94.1%
Debt/Equity
128.43
Price/Book
4.59
Beta
0.87
Market Cap
$180.5M
Avg Volume (10D)
200K
Recent Breakout Signals
No recent breakout signals detected for CVRX.
Recent Price Range (60 Days)
60D High
$9.84
60D Low
$4.37
Avg Volume
306K
Latest Close
$6.83
Get breakout alerts for CVRX
Sign up for Breakout Scanner to receive daily notifications when CVRX triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
CVRx, Inc. (CVRX) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors CVRX daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. CVRX operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.